MENU
PHAT
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Phathom Pharmaceuticals (PHAT) Earnings Date & Reports

A.I. Advisor
published Earnings

PHAT is expected to report earnings to -130 cents per share on March 04

Phathom Pharmaceuticals PHAT Stock Earnings Reports
Q4'24
Est.
$-1.31
Q3'24
Beat
by $0.15
Q2'24
Missed
by $0.24
Q1'24
Beat
by $0.09
Q4'23
Beat
by $0.27
The last earnings report on November 07 showed earnings per share of -132 cents, beating the estimate of -147 cents. With 998.42K shares outstanding, the current market capitalization sits at 621.55M.
View a ticker or compare two or three
PHAT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a biopharmaceutical company, which focuses on the development and commercialization of novel treatments for gastrointestinal diseases and disorders

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
100 Campus Drive
Phone
+1 877 742-8466
Employees
452
Web
https://www.phathompharma.com